The Drugs Controller General of India has approved the commercial launch of "Feluda", the Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) COVID-19 test, the Council of...
from NDTV News - Topstories https://ift.tt/2FMnI1j
Saturday, September 19, 2020
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment